Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

photo of Mootaz Salman smiling

Dr Mootaz Salman, Group Leader at DPAG and Research Fellow at Wolfson College, has been appointed as a Group Leader within the UK Dementia Research Institute (UK DRI) and the British Heart Foundation’s flagship Vascular Dementia Research Centre. This prestigious position comes with an award of £1.5 million to establish a major new research programme at Oxford.

The UK DRI is the UK’s leading biomedical research institute dedicated to neurodegeneration, uniting over 900 researchers across seven national centres. Its mission is to better understand the causes of diseases such as Alzheimer’s, Parkinson’s and vascular dementia, and to develop effective diagnostics, treatments and prevention strategies.

Dr Salman’s research focuses on the blood-brain barrier and how its dysfunction contributes to both neurovascular and neurodegenerative diseases. His appointment marks the first time a UK DRI Group Leader has been hosted at the University of Oxford, strengthening the University’s role in this critical national research effort.

Dr Salman said:

'It’s a real privilege to join the UK DRI and the British Heart Foundation as a Group Leader, and to bring the UK DRI to Oxford for the first time. I’m excited to build new collaborations across the UK DRI network and to drive forward impactful research at the interface of the blood-brain barrier and brain disease.'

The new group will be based at DPAG and Oxford BHF Centre for Research Excellence and will work closely with colleagues across Oxford and the wider UK DRI to uncover mechanisms of vascular dysfunction in the brain and identify novel therapeutic targets.

‘This award is a powerful example of the synergy between the UK Dementia Research Institute and the British Heart Foundation in tackling the growing challenge of vascular dementia. We are delighted to welcome Mootaz to the Oxford BHF Centre of Research Excellence, where his innovative work on the blood-brain barrier will add valuable expertise to our mission of advancing cardiovascular and neurovascular research’ comments Professor Keith Channon, Director of the BHF Oxford Centre of Research Excellence.

 

Read more here